NCT03844906View on ClinicalTrials.gov

A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 27, 2018

Primary Completion Date

March 18, 2019

Study Completion Date

April 1, 2019

Conditions
Healthy Volunteer
Interventions
DRUG

SAGE-718

SAGE-718 in combination with Ketamine

DRUG

Placebo

Placebo in combination with Ketamine

Trial Locations (2)

90806

Sage Investigational Site, Long Beach

08009

Sage Investigational Site, Berlin

All Listed Sponsors
lead

Supernus Pharmaceuticals, Inc.

INDUSTRY

NCT03844906 - A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects | Biotech Hunter | Biotech Hunter